Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real world clinical practice in Japan.
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 17 Aug 2015 New trial record